The latest quarterly R&D expense is $2.45 Million with a QoQ Growth of -10.62%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $2.45M.
$2.45M
$2.45 Million
Q2 FY2026 · 2026-06-30
-10.62%
vs. $2.74M prior quarter
20
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $2.45M | -10.62% | +24.30% |
| Q1 FY2026Period end 2026-03-31 | $2.74M | +22.64% | -25.09% |
| Q4 FY2025Period end 2025-12-31 | $2.23M | -19.43% | -34.59% |
| Q3 FY2025Period end 2025-09-30 | $2.77M | +40.74% | +12.40% |
| Q2 FY2025Period end 2025-06-30 | $1.97M | -46.13% | -31.20% |
| Q1 FY2025Period end 2025-03-31 | $3.66M | +7.08% | +5.48% |
| Q4 FY2024Period end 2024-12-31 | $3.42M | +38.45% | +92.62% |
| Q3 FY2024Period end 2024-09-30 | $2.47M | -13.86% | -44.14% |
| Q2 FY2024Period end 2024-06-30 | $2.87M | -17.41% | -35.02% |
| Q1 FY2024Period end 2024-03-31 | $3.47M | +95.55% | -27.70% |
| Q4 FY2023Period end 2023-12-31 | $1.77M | -59.85% | -60.17% |
| Q3 FY2023Period end 2023-09-30 | $4.42M | +0.20% | N/A |
| Q2 FY2023Period end 2023-06-30 | $4.41M | -8.11% | N/A |
| Q1 FY2023Period end 2023-03-31 | $4.80M | +7.72% | N/A |
| Q4 FY2022Period end 2022-12-31 | $4.45M | N/A | N/A |
| Q3 FY2022Period end 2022-09-30 | $0 | N/A | N/A |
| Q2 FY2022Period end 2022-06-30 | $0 | N/A | N/A |
| Q1 FY2022Period end 2022-03-31 | $0 | N/A | N/A |
| Q4 FY2021Period end 2021-12-31 | $0 | N/A | N/A |
| Q3 FY2021Period end 2021-09-30 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
